1. Home
  2. ROL vs BNTX Comparison

ROL vs BNTX Comparison

Compare ROL & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rollins Inc.

ROL

Rollins Inc.

BUY

Current Price

$29.64

Market Cap

22.6B

Sector

Finance

ML Signal

BUY

Logo BioNTech SE

BNTX

BioNTech SE

BUY

Current Price

$97.64

Market Cap

24.7B

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
ROL
BNTX
Founded
1948
2008
Country
United States
Germany
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.6B
24.7B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
ROL
BNTX
Price
$29.64
$97.64
Analyst Decision
Hold
Buy
Analyst Count
19
20
Target Price
$42.82
★ $117.14
AVG Volume (30 Days)
★ 7.0M
764.8K
Earning Date
10-28-2026
11-03-2026
Dividend Yield
★ 2.42%
N/A
EPS Growth
★ 13.54
N/A
EPS
★ 0.52
N/A
Revenue
★ $2,161,220,000.00
N/A
Revenue This Year
$8.65
N/A
Revenue Next Year
$8.59
$0.23
P/E Ratio
$58.79
★ N/A
Revenue Growth
★ 7.23
N/A
52 Week Low
$29.74
$79.81
52 Week High
$66.14
$124.00

Technical Indicators

Market Signals
Indicator
ROL
BNTX
Relative Strength Index (RSI) 25.22 47.54
Support Level N/A $87.31
Resistance Level $37.73 $98.81
Average True Range (ATR) 0.87 2.80
MACD -0.12 -0.18
Stochastic Oscillator 7.44 38.05

Price Performance

Historical Comparison
ROL
BNTX

About ROL Rollins Inc.

Rollins is a global leader in route-based pest control services, with operations primarily in the United States and across North, Central, and South America, Europe, the Middle East, Africa, and Australia. Its portfolio of pest-control brands includes the prominent Orkin brand, a market leader in the US and Canada, with near-national coverage. It also has a portfolio of other brands, which it uses to reach customers through alternative sales channels. Residential pest and termite prevention accounts for the majority of Rollins' services, reflecting its ongoing focus on the US and Canadian markets.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Share on Social Networks: